4//SEC Filing
Lyski James 4
Accession 0001170010-22-000046
CIK 0001170010other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 6:22 PM ET
Size
7.2 KB
Accession
0001170010-22-000046
Insider Transaction Report
Form 4
CARMAX INCKMX
Lyski James
SVP & Chief Marketing Officer
Transactions
- Award
Stock Options (Right to Buy)
2022-05-02+39,193→ 39,193 totalExercise: $91.14Exp: 2029-05-02→ Common Stock (39,193 underlying) - Tax Payment
Common Stock
2022-05-01$85.78/sh−1,926$165,212→ 19,215 total
Footnotes (2)
- [F1]The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options.
- [F2]The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 2, 2023, May 2, 2024, May 2, 2025 and May 2, 2026.
Documents
Issuer
CARMAX INC
CIK 0001170010
Entity typeother
Related Parties
1- filerCIK 0001376853
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 6:22 PM ET
- Size
- 7.2 KB